The effect of the COVID-19 pandemic on US Food and Drug Administration-funded clinical trials and natural history studies for rare diseases

BACKGROUND: Since 1983, the Orphan Product Grants Program, administered by the US Food and Drug Administration, provides funding for clinical trials and natural history studies in rare diseases. The COVID-19 pandemic created new challenges in rare disease product development. This study sought to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Kathleen L., Miller Needleman, Katherine I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105374/
https://www.ncbi.nlm.nih.gov/pubmed/37068589
http://dx.doi.org/10.1016/j.cct.2023.107198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105374/
https://www.ncbi.nlm.nih.gov/pubmed/37068589
http://dx.doi.org/10.1016/j.cct.2023.107198

Ejemplares similares